autologous T cell memory cells
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2018 (NCT03389438)
Timeline
Indications
Mechanism of action
- LymphocytesSupplementation
supplementation - lymphocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05352646 | Phase 1 | Jul 26, 2022 | Chinese Academy of Medical Sciences, Newish Technology (Beijing) Co.,Ltd. |
| NCT03432156 | Phase 2 | Feb 28, 2018 | Capital Medical University, Newish Technology (Beijing) Co.,Ltd. |
| NCT03389438 | Phase 2 | Jan 31, 2018 | Beijing Huanxing Cancer Hospital, Chinese Academy of Medical Sciences |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 2 | 2018 |
| Newish Technology (Beijing) Co.,Ltd. | Government | 2 | 1 | 2 | 2018 |
| Beijing Huanxing Cancer Hospital | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
4 organizations
Page 1 / 1